Results 91 to 100 of about 16,217 (195)

Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1

open access: yesAdvanced Science
Broadly neutralizing antibodies are proposed as therapeutic and prophylactic agents against HIV‐1, but their potency and breadth are less than optimal.
Jianliang Xu   +33 more
doaj   +1 more source

Nanobodies targeting SARS-CoV-2 papain-like protease exert dual antiviral and anti-inflammatory effects. [PDF]

open access: yesJ Virol
Liu G   +11 more
europepmc   +1 more source

Identification and characterization of Nanobodies targeting the EphA4 receptor

open access: yes, 2017
The ephrin receptor A4 (EphA4) is one of the receptors in the ephrin system that plays a pivotal role in a variety of cell-cell interactions, mostly studied during development. In addition, EphA4 has been found to play a role in cancer biology as well as
Joyce, P   +16 more
core  

Nanobodies against Plasmodium adhesins that block receptor engagement and malaria parasite invasion. [PDF]

open access: yesBiochem J
D Sa J   +13 more
europepmc   +1 more source

A neuraminidase-targeting nanobody as a therapeutic candidate against influenza A and B viruses. [PDF]

open access: yesJ Virol
Liu D   +11 more
europepmc   +1 more source

Correction: Bispecific nanobodies targeting Bet v 1 and ICAM-1 decrease respiratory epithelial penetration of Bet v 1. [PDF]

open access: yesFront Immunol
Zettl I   +11 more
europepmc   +1 more source

Self-Blinking Dye Restores Efficient Use of Nanobodies in Single-Molecule Localization Microscopy. [PDF]

open access: yesNano Lett
Basak S   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy